Construction and validation of a prognostic risk model for uterine corpus endometrial carcinoma based on alternative splicing events

[1]  A. Zhang,et al.  Identification of Alternative Splicing-Related Genes CYB561 and FOLH1 in the Tumor-Immune Microenvironment for Endometrial Cancer Based on TCGA Data Analysis , 2022, Frontiers in Genetics.

[2]  Guoshuang Shen,et al.  Expression and clinical prognostic value of CYB561 in breast cancer , 2022, Journal of Cancer Research and Clinical Oncology.

[3]  Yu-ichiro Nakajima.  Scrib module proteins: control of epithelial architecture and planar spindle orientation. , 2021, The international journal of biochemistry & cell biology.

[4]  Y. Shao,et al.  SCRIB Promotes Proliferation and Metastasis by Targeting Hippo/YAP Signalling in Colorectal Cancer , 2021, Frontiers in Cell and Developmental Biology.

[5]  K. Jang,et al.  SCRIB Is Involved in the Progression of Ovarian Carcinomas in Association with the Factors Linked to Epithelial-to-Mesenchymal Transition and Predicts Shorter Survival of Diagnosed Patients , 2021, Biomolecules.

[6]  Henry M. Quillian,et al.  Association of Missense Mutation in FOLH1 With Decreased NAAG Levels and Impaired Working Memory Circuitry and Cognition. , 2020, The American journal of psychiatry.

[7]  L. French,et al.  Folate hydrolase‐1 (FOLH1) is a novel target for antibody‐based brachytherapy in Merkel cell carcinoma , 2020, Skin health and disease.

[8]  P. Jordan,et al.  Alternative Splicing: Expanding the Landscape of Cancer Biomarkers and Therapeutics , 2020, International journal of molecular sciences.

[9]  Kefei Yuan,et al.  ARHGEF11 promotes proliferation and epithelial-mesenchymal transition of hepatocellular carcinoma through activation of β-catenin pathway , 2020, Aging.

[10]  K. Jang,et al.  FAM83H and SCRIB stabilize β-catenin and stimulate progression of gastric carcinoma , 2020, Aging.

[11]  K. Zhao,et al.  Serine/threonine kinase 32C is overexpressed in bladder cancer and contributes to tumor progression , 2018, Cancer biology & therapy.

[12]  F. Khuri,et al.  MAST1 Drives Cisplatin Resistance in Human Cancers by Rewiring cRaf-Independent MEK Activation. , 2018, Cancer cell.

[13]  A. Talhouk,et al.  Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[14]  W. Cong,et al.  Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1. , 2017, Gastroenterology.

[15]  M. Ladomery.  Aberrant Alternative Splicing Is Another Hallmark of Cancer , 2013, International journal of cell biology.

[16]  Steven J. M. Jones,et al.  Integrated genomic characterization of endometrial carcinoma , 2013, Nature.

[17]  R. Xu,et al.  Prognostic relevance of melanoma antigen D1 expression in colorectal carcinoma , 2012, Journal of Translational Medicine.

[18]  J. Borg,et al.  Scrib Controls Cdc42 Localization and Activity to Promote Cell Polarization during Astrocyte Migration , 2006, Current Biology.

[19]  R. Roberts,et al.  An amazing sequence arrangement at the 5′ ends of adenovirus 2 messenger RNA , 1977, Cell.